Omega Diagnostics Group PLC - sells wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics market - Notes announcement by UK Rapid Test Consortium that Abingdon Health has gained confirmation from the US Food & Drug Administration that Abingdon has completed notification process under the Policy for Coronavirus Disease Tests During the Public Health Emergency.
Abingdon has submitted an Emergency Use Authorization request to the FDA for the AbC-19 rapid test.
Current stock price: 54.00 pence
Year-to-date change: more than tripled from 14.22p
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:


(Alliance News) - Omega Diagnostics Group PLC on Tuesday said that Group Finance Director Chris Lea has stepped down with immediate effect, as he is b...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:


(Alliance News) - Omega Diagnostics Group PLC on Tuesday said that Group Finance Director Chris Lea has stepped down with immediate effect, as he is b...


(Alliance News) - Omega Diagnostics Group PLC on Thursday said its annual loss widened as operational difficulties caused its revenue to plunge.


Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Expects annual revenue in the year that ended March 31 to be GBP7.5 million f...


(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.


(Sharecast News) - Medical diagnostics company Omega said on Monday that revenues had contracted in the twelve months ended 31 March.